Login to Your Account



FDA Approval Opens Bright New Year for More TB Cocktails

By Mari Serebrov
Washington Editor

Wednesday, January 2, 2013
The FDA's end-of-the-year approval of Janssen Therapeutics' Sirturo rang in a new year of hope for patients with multidrug-resistant pulmonary tuberculosis (MDR-TB). And it brought good cheer to other biopharma companies developing their own cocktails intended to make the deadly form of TB toast.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription